In collaboration with OUTBio Greater New York, we hosted a #PrideMonth panel, “Being an LGBTQIA+ Leader in Life Sciences,” which was moderated by our Chief People Officer, Daniel Pichl and featured leaders from across the industry. See what they have to say.

SpringWorks is happy to be a sponsor of the Global NF Conference hosted by the Children's Tumor Fdn. We have enjoyed meeting with the #NF research and clinical communities at this conference. #nfcon24

What does it mean to own your care? For Antwan, an #NF1-PN patient, it means knowing that when something feels off in your body, you should not be afraid to contact your doctor about it. Sign up to stay connected and receive information or resources: nf1pn.com/sign-up/

Thank you, BlackDoctor, for sharing Antwan’s inspiring #NF1-PN journey. The optimism, strength and resilience of patients like him motivates us to dig deeper and press beyond “good enough” to find more options. Read about Antwan’s journey: blackdoctor.org/ive-had-18-sur…

We are happy to share that we have completed the submission of our New Drug Application to the FDA for our investigational MEK inhibitor for the treatment of children and adults with #NF1-PN. Learn more: ir.springworkstx.com/news-releases/…

That’s a wrap on #PrideMonth! Thank you to our OUT SWTX+ employee resource group for cultivating a culture of allyship and for raising awareness and understanding about LGBTQIA+ identities. #HappyPride

Seize a unique opportunity and help us deliver a potentially best-in-class therapy for children and adults with #NF1-PN. Learn more about joining our NF1-PN commercial team: springworkstx.com/careers/join-c…

July is #SarcomaAwarenessMonth. Thank you nwsarcoma, Rein in Sarcoma, Sarcoma Alliance for Research through Collaboration, and Sarcoma Foundation of America for raising awareness of the devastating impact of sarcomas. #CureSarcoma

Welcome to the new #SpringWorkers who recently joined us. We’re thrilled to have you here! Interested in becoming a SpringWorker? Learn more: springworkstx.com/careers/

Thank you to our 2024 Summer interns for your hard work and contributions. Read what some of them have learned so far from their experiences. #InternAppreciationDay

We are excited to welcome Dr. Martin Mackay to our Board of Directors. Read the full announcement: ir.springworkstx.com/news-releases/…

Antwan, 38, was diagnosed with #NF1-PN as a toddler, but he never let it hold him back from pursuing his dreams. He inspires us to dig deeper because we know that NF1-PN patients need more solutions. Business Insider members can view the full piece here: businessinsider.com/rare-disease-v…

Our #NF1-PN Commercial Team is hiring and looking for individuals who care hard, think hard and act with urgency. Robb Folts, Vice President, US Sales, discusses this unique opportunity. Apply today: springworkstx.com/careers/join-c…

We are honored that OGSIVEO® has been nominated for the prestigious #PrixGalien USA award for Best Product for Rare/Orphan Diseases. We are looking forward to the awards ceremony on November 7th when the winners will be announced. prnewswire.com/news-releases/…

Our “Caring hard” value also extends to our local communities. Thank you to our Multicultural Inclusion Experience’s (MIX) and Thrive employee resource groups for hosting a school supply drive to benefit ISLA Learn more about them: laislaschool.org

That’s a wrap for our 2024 Summer interns. We appreciate your hard work, and we wish you success in the upcoming academic year. Read on to find out what our interns took away from their experience.

We are proud to sponsor HBAnet’s “Amplifying Your Leadership Voice: Ambition without Ego” event on August 22 in Durham, NC. Thank you to Kristin Patterson and Betsy George for participating in this important conversation.

The FDA has granted Priority Review to our New Drug Application for our investigational MEK inhibitor for children and adults with #NF1-PN. Our EU Marketing Authorization submission has also been validated by the European Medicines Agency. Learn more: ir.springworkstx.com/news-releases/…

We’re just three days away from #DesmoidTumorAwarenessMonth. Follow SpringWorks and Desmoid Tumor Research Foundation during September to learn more about #DesmoidTumors and to hear inspiring stories of people living with these devastating tumors.

This #DesmoidTumorAwarenessMonth, we are proud to say that patients now have an FDA-approved treatment, which has rapidly become the standard of care systemic therapy for patients with #DesmoidTumors. Learn more: springworkstx.com/patients/desmo…